Evidence map›Paper›PMID 28056894›Full record

Trial reportBMC public health2017

Study Protocol: The Norfolk Diabetes Prevention Study [NDPS]: a 46 month multi - centre, randomised, controlled parallel group trial of a lifestyle intervention [with or without additional support from lay lifestyle mentors with Type 2 diabetes] to prevent transition to Type 2 diabetes in high risk groups with non - diabetic hyperglycaemia, or impaired fasting glucose.

Melanie Pascale, Nikki Murray, Max Bachmann, Garry Barton, Allan Clark, Amanda Howe, Colin Greaves, Mike Sampson

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMC public health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Melanie PascaleNorfolk Diabetes Prevention Study, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK.
Nikki MurrayNorfolk Diabetes Prevention Study, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK.
Max BachmannDepartment of Population Health and Primary Care, Norwich Medical School, University of East Anglia, Norwich, UK.
Garry BartonHealth Economics Group, Norwich Medical School, University Of East Anglia, Norwich, UK.
Allan ClarkNorwich Clinical Trials Unit, Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, UK.
Amanda HoweDepartment of Population Health and Primary Care, Norwich Medical School, University of East Anglia, Norwich, UK.
Colin GreavesUniversity of Exeter Collaboration for Academic Primary Care (APEx), University of Exeter Medical School, Exeter, UK.
Mike SampsonNorfolk Diabetes Prevention Study, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK. mike.sampson@nnuh.nhs.uk.ORCID 0000-0002-1433-2319
University of East Anglia · GBNorfolk and Norwich University Hospital · GBUniversity of Exeter · GB

Funding

Department of Health PB-PG-0609-19144Department of Health PDA/02/06/031Department of Health RP-PG-0109-10013Department of Health RP-PG-0606-1099
6 · The paper itself

Abstract

backgroundThis 7 year NIHR programme [2011-2018] tests the primary hypothesis that the NDPS diet and physical activity intervention will reduce the risk of transition to type 2 diabetes (T2DM) in groups at high risk of Type 2 diabetes. The NDPS programme recognizes the need to reduce intervention costs through group delivery and the use of lay mentors with T2DM, the realities of normal primary care, and the complexity of the current glycaemic categorisation of T2DM risk.

methodsNDPS identifies people at highest risk of T2DM on the databases of 135 general practices in the East of England for further screening with ab fasting plasma glucose and glycosylated haemoglobin [HbA1c]. Those with an elevated fasting plasma glucose [impaired fasting glucose or IFG] with or without an elevated HbA1c [non -diabetic hyperglycaemia; NDH] are randomised into three treatment arms: a control arm receiving no trial intervention, an arm receiving an intensive bespoke group-based diet and physical activity intervention, and an arm receiving the same intervention with enhanced support from people with T2DM trained as diabetes prevention mentors [DPM]. The primary end point is cumulative transition rates to T2DM between the two intervention groups, and between each intervention group and the control group at 46 months. Participants with screen detected T2DM are randomized into an equivalent prospective controlled trial with the same intervention and control arms with glycaemic control [HbA1c] at 46 months as the primary end point. Participants with NDH and a normal fasting plasma glucose are randomised into an equivalent prospective controlled intervention trial with follow up for 40 months. The intervention comprises six education sessions for the first 12 weeks and then up to 15 maintenance sessions until intervention end, all delivered in groups, with additional support from a DPM in one treatment arm. DISCUSSION: The NDPS programme reports in 2018 and will provide trial outcome data for a group delivered diabetes prevention intervention, supported by lay mentors with T2DM, with intervention in multiple at risk glycaemic categories, and that takes into account the realities of normal clinical practice.

trial registrationISRCTN34805606 (Retrospectively registered 16.3.16).

Indexed as

Blood GlucoseLife StyleResearch DesignAdultAgedDiabetes Mellitus, Type 2DietEnglandExerciseFastingFemaleHumansHyperglycemiaMaleMentoringMentorsBlood GlucoseDiabetes preventionImpaired fasting glucoseLay mentorsLifestyle interventionNon diabetic hyperglycaemiaType 2 diabetes

Identifiers

PMID28056894
PMCPMC5217324
OpenAlexW2570793769

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.